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OBJECTIVE—Thyroid hormone accelerates energy expendi-
ture; thus, hypothyroidism is intuitively associated with obesity.
However, studies failed to establish such a connection. In brown
adipose tissue (BAT), thyroid hormone activation via type 2
deiodinase (D2) is necessary for adaptive thermogenesis, such
that mice lacking D2 (D2KO) exhibit an impaired thermogenic
response to cold. Here we investigate whether the impaired
thermogenesis of D2KO mice increases their susceptibility to
obesity when placed on a high-fat diet.
RESEARCH DESIGN AND METHODS—To test this, D2KO
mice were admitted to a comprehensive monitoring system
acclimatized to room temperature (22°C) or thermoneutrality
(30°C) and kept either on chow or high-fat diet for 60 days.
RESULTS—At 22°C, D2KO mice preferentially oxidize fat, have
a similar sensitivity to diet-induced obesity, and are supertolerant
to glucose. However, when thermal stress is eliminated at ther-
moneutrality (30°C), an opposite phenotype is encountered, one
that includes obesity, glucose intolerance, and exacerbated he-
patic steatosis. We suggest that a compensatory increase in BAT
sympathetic activation of the D2KO mice masks metabolic reper-
cussions that they would otherwise exhibit.
CONCLUSIONS—Thus, upon minimization of thermal stress,
high-fat feeding reveals the defective capacity of D2KO mice for
diet-induced thermogenesis, provoking a paradigm shift in the
understanding of the role of the thyroid hormone in metabolism.
Diabetes 60:1082–1089, 2011
O
besity results as the consequence of a positive
energy balance, where energy intake is greater
than energy expended. One of the key mole-
cules in this balance is thyroid hormone, which
potently accelerates the resting energy expenditure (1,2).
The adaptive (cold-induced) energy expenditure is con-
trolled by the sympathetic nervous system and is also ac-
celerated by thyroid hormone. In response to cold exposure,
the sympathetic nervous system stimulates brown adipose
tissue (BAT) and activates uncoupling protein 1 (UCP1) (3),
which is transcriptionally upregulated by thyroid hor-
mone (4). In addition, the sympathetic nervous system
also stimulates the cAMP-inducible type 2 deiodinase (D2)
that ampliﬁes thyroid hormone signaling in BAT by locally
converting the prohormone T4 to the active form of thyroid
hormone, T3 (5). Disruption of this pathway, as in mice with
targeted inactivation of D2 (D2 knockout [D2KO] mice),
leads to impaired BAT thermogenesis and hypothermia
during cold exposure (6,7).
Sympathetic activity to BAT is also augmented by high-
fat feeding (8), leading to diet-induced thermogenesis, but
the role played by thyroid hormone in this process is
largely unclear. Although there is an intuitive assump-
tion that hypothyroid individuals/animals tend to be obese,
the compilation of a vast array of data from individuals
transitioning from hypo- to hyperthyroidism and vice
versa exhibits only minor changes in body composition
(9–11). In fact, we have reported earlier that hypothy-
roid rats living at room temperature placed on a high-fat
diet do not accumulate more fat than euthyroid controls
(12), questioning a role for thyroid hormone in this
pathway.
However, it is conceivable that compensatory mecha-
nisms activated during hypothyroidism may obscure the
relevance (if any) of thyroid hormone on diet-induced
thermogenesis. In this case, such mechanisms are likely to
stem from the sympathetic nervous system, given that
sympathetic activity ﬂuctuates in an opposite direction as
thyroid hormone signaling (13–15). In fact, the BAT-speciﬁc
decrease in thyroid hormone signaling seen in the D2KO
mouse is sufﬁcient to trigger a compensatory increase in
BAT sympathetic activity during cold exposure, upregu-
lating a series of T3-responsive metabolic parameters in
the tissue, including UCP1 mRNA levels (7).
Here, we report that even at room temperature there is
a chronic increase in BAT sympathetic activity. We suggest
that this activity compensates for the decreased thyroid
hormone signaling, thus masking profound metabolic
alterations in D2KO mice. If reared at 22°C, D2KO mice
have increased tolerance to glucose and gain the same
weight as controls on a high-fat diet. However, when the
increase in BAT sympathetic activity is minimized by
rearing animals at 30°C, D2KO mice develop intolerance to
glucose and become more susceptible to diet-induced
obesity. Remarkably, a consistent feature of the D2KO
mice, independent of ambient temperature, is liver steato-
sis, which becomes most severe under high-fat feeding
after acclimatization to thermoneutrality. Thus, these
results provoke a paradigm shift in the understanding of
the role of the thyroid hormone in metabolism, uncover-
ing a hitherto unrecognized function for thyroid hormone
in prevention of obesity and its metabolic complications.
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ORIGINAL ARTICLERESEARCH DESIGN AND METHODS
Animals. All studies were performed under a protocol approved by the local
Institutional Animal Care and Use Committee. C57BL/6J and D2KO (7) mice
approximately 3 months old were used from our established colonies, kept
at room temperature (22°C), at thermoneutrality (30°C; Columbus Instru-
ments, Columbus, OH), or in the cold (5°C), with a 12-h dark/light cycle
starting at 0600 h, and housed in standard plastic cages with four male mice
per cage. Animals were kept on standard chow diet (3.5 kcal/g; 28.8% pro-
tein, 58.5% carbohydrate, 12.7% fat) (5010 LabDiet laboratory autoclavable
rodent diet; PMI Nutrition, Richmond, IN) or a high-fat diet (4.5 kcal/g; 15.3%
protein, 42.7% carbohydrate, 42% fat) (TD 95121; Harlan Teklad, India-
napolis, IN) as indicated. Twenty-four-hour caloric intake was measured at
the indicated times using the Oxymax Feed Scale device (Columbus Instru-
ments). At the appropriate times, animals were killed with carbon dioxide.
Tissue samples were obtained and immediately snap-frozen for further analyses.
Body composition. Lean body mass (LBM) and fat mass were determined by
dual-energy X-ray absorptiometry (DEXA; Lunar Pixi, Janesville, WI). For
the procedure, mice were anesthetized with ketamine-xylazine (200 mg/kg and
7–20 mg/kg) before imaging.
Indirect calorimetry. Oxygen consumption (VO2), respiratory exchange ratio
(RER), and locomotor activity were continuously measured using the Oxymax
System 4.93 (C.L.A.M.S.; Columbus Instruments). The animals were placed in
the C.L.A.M.S. with free access to food and water, allowing them to acclima-
tize in individual metabolic cages for 48 h before any measurements. Sub-
sequently, 24-h metabolic proﬁles were generated in successive 14-min cycles.
VO2 was expressed as milliliters per kilogram LBM per minute. Studies were
performed at 30°C, 22°C, or at 5°C for the indicated times. The sensor was
calibrated against a standard gas mix containing deﬁned quantities of O2 and
CO2. Spontaneous locomotor activity was recorded with OPTO-M3 Activity
Application Device (Columbus Instruments) (16). All analyses for VO2 and RQ
were made considering the area under the curve (i.e., VO2 vs. time; respiratory
quotient [RQ] vs. time) for each individual animal.
Glucose tolerance test. Tolerance to a glucose load was studied in overnight
fasted live mice following intraperitoneal injection of 1 g/kg glucose. Blood
samples were obtained from the tail vein and measured with Glucometer Elite
(Bayer Tarrytown, NY) at different time points.
mRNA analysis. Total RNA was extracted using the RNeasy kit (Qiagen,
Valencia, CA) according to the manufacturer’s instructions, quantiﬁed with
a Nano-Drop spectrophotometer and 2.5 mg reverse-transcribed into cDNA by
using a high capacity cDNA reverse transcription kit (Applied Biosystems,
Foster City, CA). Genes of interest were measured by quantitative RT-PCR
(Bio-Rad iCycler iQ Real-Time PCR Detection System; Bio-Rad Laboratories
Hercules, CA) using the iQ SYBR Green Supermix (Bio-Rad Laboratories)
with the following conditions: 15 min at 94°C (Hot Start), 30–50 s at 94°C,
30–50 s at 55–60°C, and 45–60 s at 72°C for 40 cycles. A ﬁnal extension at
72°C for 5 min was performed as well as the melting curve protocol to verify
the speciﬁcity of the amplicon generation. Standard curves consisting of
four to ﬁve points of serial dilution of mixed experimental and control
groups cDNA were prepared for each assay. Cyclophilin A was used as
a housekeeping internal control gene. The coefﬁcient of correlation (r
2)
FIG. 1. Effect of ambient temperature on body composition, indirect calorimetry, and NE turnover of D2KO mice. A: Body composition as measured
by DEXA in WT and D2KO mice acclimatized at the indicated ambient temperatures; body weights were as follows: D2KO, 21.55 6 0.46 and
WT, 25.4 6 0.6 g at 22°C; D2KO, 22.4 6 0.45 and WT, 23.9 6 0.6 g at 30°C. B: Same as in A, except that what is shown is VO2. C: Same as in B, except
that what is shown is RQ. D: Interscapular BAT NE turnover at the indicated time points. All animals were kept on chow diet. Measurements were
made during the light cycle. Entries are means 6 SE of four to ﬁve animals; a is P < 0.01 vs. animals of the same genotype. NS, not signiﬁcant.
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between 80 and 110%. Results are expressed as ratios of test mRNA to
cyclophilin A mRNA.
Interscapular BAT norepinephrine turnover. Interscapular BAT (IBAT)
norepinephrine (NE) turnover was measured in mice acclimatized at room
temperature (22°C) or at thermoneutrality (30°C). Mice were anesthetized
with urethane (1.2 g/kg i.p.) and given 300 mg/kg a-methyl parathyrosine
(a-MT) to block NE synthesis as described (7). Mice were killed at 0, 1, 2, 3, or
4 h after the a-MT injection, and the IBAT was processed for NE measurement
by radioimmunoassay (Alpco Diagnostics, Windham, NH).
Biochemical analyses. Immediately after mice were killed, liver fragments
were obtained and ﬁxed in 4% paraformaldehyde in 0.1 mL PBS for 24 h at 4°C,
frozen, sectioned, stained with Oil Red O, and counterstained with Meyer’s
hematoxylin. Frozen liver fragments (~200 mg) were homogenized, and lipids
were extracted using chloroform/methanol (2:1) and 0.05% sulfuric acid as
described (17). An aliquot of the organic phase was collected and mixed with
chloroform containing 1% Triton X-100, dried under nitrogen stream, and
resuspended in water. Triglycerides were determined using a commercially
available kit (Sigma-Aldrich, St. Louis, MO).
Statistical analysis. All data were analyzed using Prism software (GraphPad
Software, Inc., San Diego, CA) and are expressed as means 6 SE. One-way
ANOVA was used to compare more than two groups, followed by the Newman-
Keuls multiple comparison test to detect differences between groups. The
Student t test was used to compare the differences between two groups. P ,
0.05 was used to reject the null hypothesis.
RESULTS
D2KO mouse metabolic proﬁle depends on ambient
temperature. Under the mild thermal stress conditions of
room temperature (22°C) and on a chow diet (12.7% fat),
D2KO mice have similar caloric intake (Supplementary
Fig. 1A) and percent composition of lean and fat masses as
age-matched wild-type (WT) controls (Fig. 1A). Even after
2 weeks of acclimatization at 30°C, percent body compo-
sition remains unchanged in chow-fed D2KO and WT mice
(Fig. 1A).
We next analyzed parameters of energy homeostasis
using indirect calorimetry. At 22°C, despite having a simi-
lar rate of oxygen consumption (VO2;F i g .1 B), D2KO mice
had a relatively higher percentage of fatty acid oxidation
compared with WT, as reﬂected by a signiﬁcantly lower
respiratory exchange ratio (RQ; Fig. 1C). These ﬁndings
led us to analyze the BAT NE turnover rate as an index of
sympathetic stimulation of this tissue. Remarkably, al-
though WT controls had a NE turnover rate of about 9.5 6
0.6%/h, D2KO animals maintained a rate of ~15 6 1.1%/h
(Fig. 1D; P , 0.01).
Thus, to examine whether this difference in sympathetic
activity depends on ambient temperature, D2KO and WT
mice were acclimatized at 30°C. In this setting, the BAT NE
turnover rate was reduced in both groups to ~5%/h, with
no differences between WT and D2KO mice (Fig. 1D). This
was paralleled by a decrease in VO2 as compared with the
rates at 22°C, with D2KO mice maintaining similar values
as WT mice (Fig. 1B). Of interest, thermoneutrality dissi-
pated the differences in RQ between WT and D2KO mice
(Fig. 1C), with RQ increasing signiﬁcantly from 22°C values
FIG. 2. Effect of high-fat feeding at room temperature on body composition and indirect calorimetry. D2KO and WT mice were fed with high-fat diet
for 8 weeks and kept at 22°C (A–D). A: Body composition as measured by DEXA in WT and D2KO mice at the end of the experiment; body weights
were D2KO, 26.9 6 2.68 and WT, 36.3 6 2.5 g. B:V O2 was measured at day 1 and day 60 in WT and D2KO, after the animals started on the high-fat
feeding. C: Same as B, except that what is shown is RQ. D: Body weight gain in WT and D2KO mice. Entries are means 6 SE of four to ﬁve animals;
a is P < 0.05 vs. animals of the same genotype.
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ferences in food consumption between D2KO and WT mice
were noted (Supplementary Fig. 1).
D2KO mice have similar weight gain on high-fat diet
at room temperature. To test the sensitivity of D2KO
mice to diet-induced obesity, groups of age-matched WT
and D2KO mice maintained at 22°C were placed on a high-
fat diet (42% fat). No major differences were found be-
tween WT and D2KO mice (Fig. 2). After 60 days of ad
libitum high-fat diet feeding, both groups experienced
a similar increase in body fat (from about 20–33%; P ,
0.01) as reﬂected in the body composition analyses (Fig. 1A
vs. Fig. 2A). After 60 days, there was a minimal decrease in
VO2 in both groups (Fig. 2B), with RQ remaining slightly
lower in D2KO animals (Fig. 2C; P , 0.05). Despite similar
caloric intake in both groups (Supplementary Fig. 1B),
D2KO mice gained slightly less body weight as compared
with WT (30 vs. 37%), although differences did not reach
statistical signiﬁcance (Fig. 2D; P =0 . 2 ) .
Thermoneutrality reveals sensitivity to diet-induced
obesity in D2KO mice. To test the hypothesis that the
increased metabolism at 22°C overrules the effect of hy-
pothyroidism, we next repeated the 60-day feeding period
with high-fat diet in WT and D2KO mice that were main-
tained at 30°C.
This time, major differences were indeed found between
WT and D2KO mice (Fig. 3). After 60 days of ad libitum
high-fat diet feeding, D2KO animals experienced a much
greater increase in body fat (~20–45%; P , 0.01) compared
with WT animals (~20–35%; P , 0.01) as reﬂected in the
body composition analyses (Fig. 1A v s .F i g .3 A). There
was a small but signiﬁcant increase in VO2 in both groups
(Fig. 3B), but, most importantly, the difference in RQ was
dissipated on the very day 1 of high-fat feeding (Fig. 3C).
Although no differences in caloric intake were observed
between D2KO and WT animals under these conditions
(Supplementary Fig. 1C), D2KO mice had a 66% increase in
body weight, which was nearly twice that of the 37% in-
crease seen in WT mice (Fig. 3D; P , 0.01). The increased
susceptibility of the D2KO mouse to obesity at 30°C could
also be noted upon visual inspection (Fig. 3E). That the
increased fat gain was attributable to defective diet-induced
thermogenesis was supported by a ;80% lower UCP1 ex-
pression in the BAT of D2KO mice (Fig. 3F).
D2KO exhibit liver steatosis and glucose intolerance.
Histological and biochemical liver analysis revealed in-
creased triglyceride deposits in D2KO mice that were kept
on a chow diet at 22°C (;30%; Table 1; Fig. 4A and E).
Acclimatization to 30°C did not signiﬁcantly change fat
deposition in liver of both groups of animals (Table 1;
FIG. 3. Effect of high-fat feeding at thermoneutrality on body composition and indirect calorimetry. D2KO and WT mice were acclimatized at 30°C
for 2 weeks and subsequently fed with high-fat diet for 8 weeks while at 30°C (A–F). A: Body composition as measured by DEXA in WT and D2KO
mice at the end of the experiment; body weights were D2KO, 41.6 6 1.23 and WT, 39.45 6 1.8 g. B:V O2 was measured at day 1 and day 60 in WT and
D2KO. C: Same as B, except that what is shown is RQ. D: Body weight gain in WT and D2KO mice. At day 1 body weights were D2KO, 25.5 6 0.57 and
WT, 28.43 6 1.12 g. E: Image of representative WT and D2KO mice at the end of the experiment. F: UCP1/Cyclophilin A mRNA levels in the BAT at
the end of the experiment. Entries are means 6 SE of four to ﬁve animals; *P < 0.01 vs. WT. (A high-quality color representation of this ﬁgure is
available in the online issue.)
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D2KO were minimized (;22%; P =0 . 0 6 ;T a b l e1 ;F i g .4 B
and F). High-fat feeding for 60 days increased fat de-
position in the WT liver by ;3.7-fold at 22°C and ;5.0-
fold at 30°C (Table 1; Fig. 4C and D). In the D2KO livers,
the increase in fat content reached ;3.6-fold at 22°C
and, remarkably, 10-fold at 30°C (Table 1 and Fig. 4G
and H). Although the differences of liver triglyceride
content between WT and D2KO animals kept on a high-
fat diet remained relatively stable at 22°C (;28%; Table 1
and Fig. 4C and G), moving the animals to 30°C dra-
matically increased this difference to ;2.7-fold (Table 1
and Fig. 4D and H).
The more extensive fat deposition in the liver of D2KO
animals and its sensitivity to acclimatization temperature
suggested that lipolysis and/or the level of serum fatty
acids (nonesteriﬁed fatty acids [NEFA]) was playing a role.
However, regardless of the diet, NEFA serum levels were
not different between WT and D2KO animals at 22°C
(Table 1). Of note, high-fat feeding did increase NEFA
levels in both groups (Table 1). In addition, only WT ani-
mals experienced decreased NEFA serum levels when
maintained at 30°C, which also does not correlate with our
ﬁndings of fat deposition in the liver (Table 1). Thus, it
does not seem that differences in serum NEFA levels
contribute to liver steatosis in the D2KO animals.
Remarkably, the D2KO animals acclimatized at 22°C
are substantially more tolerant to a glucose load than WT
(Fig. 5A). Acclimatization to 30°C dissipated this difference
in glucose handling (Fig. 5B), suggesting that chronic
sympathetic BAT stimulation observed in D2KO mice at
22°C could make the animals more tolerant to glucose.
This is supported by studies in rats, where cold exposure
enhanced disposal of circulating glucose as a result of BAT
activation (18). It is noteworthy that during high-fat feed-
ing at 22°C, there were no differences between D2KO and
WT animals in terms of glucose tolerance (Fig. 5C). During
acclimatization at 30°C, feeding with a high-fat diet pro-
moted glucose intolerance in D2KO mice, which were less
capable of disposing of a glucose load (Fig. 5D).
DISCUSSION
Thyroid hormone and the sympathetic nervous system
share a number of common target systems, including cel-
lular pathways involved in metabolic control (1). BAT
capitalizes on the synergistic relationship between the
sympathetic and thyroid hormone systems for activation of
adaptive thermogenesis. BAT expresses D2, which itself is
a cAMP-responsive gene, increasing local T3 concentra-
tion four- to ﬁvefold during sympathetic stimulation with-
out signiﬁcant alteration of systemic T3 levels (19); the end
FIG. 4. Effect of acclimatization temperature and/or diet on lipid deposition in the liver. Oil Red O staining of liver sections obtained from D2KO
and WT fed with chow or high-fat diet (HFD) for 8 weeks, acclimatized to 22°C or 30°C, as indicated (A–H) is shown. A and B: D2KO and WT fed
with chow diet, acclimatized to 22°C. C and D: Same as A and B, except acclimatization was at 30°C. E and F: D2KO and WT fed with high-fat diet
for 8 weeks, acclimatized to 22°C. G and H: Same as E and F, except acclimatization was at 30°C. Scale bar is 50 mm. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
TABLE 1
Liver triglycerides content (in milligrams per gram) and serum NEFA levels (in milliequivalents per liter) in WT and D2KO mice kept
on chow or high-fat diet: effect of environment temperature
Liver triglycerides Serum NEFA
Chow diet High-fat diet Chow diet High-fat diet
22°C 30°C 22°C 30°C 22°C 30°C 22°C 30°C
Genotype
WT 25 6 0.7 47 6 2.3 93 6 2
b 126 6 42
c 0.62 6 0.06 0.3 6 0.05
b 0.9 6 0.06
b 0.66 6 0.12
g
D2KO 33 6 0.9* 58 6 4.7
a 119 6 5**
e 339 6 92*
d,f 0.49 6 0.06 0.6 6 0.13* 0.9 6 0.05
h 0.99 6 0.04*
i
All values in the table are means 6 SE of four to ﬁve animals. *P , 0.05; **P , 0.005;
aP , 0.057 vs. WT on the same temperature and diet;
bP , 0.05 vs. 22°C on chow diet;
cP , 0.01 vs. 30°C on chow diet;
dP , 0.001 vs. 22°C on high-fat diet;
eP , 0.001 vs. 22°C on chow diet;
fP , 0.001
vs. 30°C on high-fat diet;
gP , 0.05 vs. 30°C on chow diet;
hP , 0.01 vs. 22°C on chow diet;
iP , 0.01 vs. 30°C on chow diet by one-way ANOVA.
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UCP1, which is both cAMP- and T3-sensitive (5,20). Here,
we show that when D2-mediated T3 production is prevented,
as with the D2KO mouse, there is a compensatory increase
in BAT sympathetic activity to offset the tissue-level hy-
pothyroidism (Fig. 1D). We suggest that this compensatory
sympathetic response neutralizes much of the phenotype
that D2KO mice would otherwise exhibit as a result of the
disruption in thyroid hormone signaling (Figs. 1 and 2). At
22°C, the D2KO mouse preferentially oxidizes fat (Fig. 1C),
has a similar sensitivity to diet-induced obesity (Fig. 2), and
is supertolerant to a glucose load (Fig. 5A). However, by
eliminating thermal stress and rearing these animals at
thermoneutrality (30°C), an opposite phenotype is encoun-
tered, one that includes obesity (Fig. 3) and glucose in-
tolerance (Fig. 5D). These results deﬁn eac r i t i c a lr o l e
played by D2 in adaptive thermogenesis, revealing a novel
aspect of the thyroid-adrenergic synergism.
Uncoupling substrate oxidation from ATP synthesis is
an important pathway for maintaining body temperature
when small mammals are exposed to cold. Given recruit-
ment of BAT and increased adrenergic responsiveness in
mice fed a cafeteria diet (21), a similar pathway may be
harnessed to activate BAT and dissipate excess calories as
a form of diet-induced thermogenesis. In fact, activation of
the adrenergic system has been used to counteract obesity
(22). However, similar to our present ﬁndings, studies
performed with high-fat feeding of UCP1
2/2 mice, which
were expected to become obese, yielded drastically dif-
ferent phenotypes that were dependent on whether am-
bient temperature prevented or promoted thermal stress.
Although UCP1
2/2 mice reared at 30°C are prone to diet-
induced obesity, under subthermoneutral temperatures,
UCP1
2/2 mice are lean with elevated D2 in inguinal fat
(23,24). It has been suggested that in the absence of the
UCP1 pathway, alternative mechanisms are triggered to
maintain body temperature, such as an increase in thyroid
hormone signaling. Consequently, when both UCP1 and
a thyroid hormone-responsive mechanism, glycerol phos-
phate cycling, are inactivated, mice accumulate even less
fat mass at 22°C (25). Our current ﬁndings support and
conﬁrm this notion of the importance of thyroid hormone
(and its activation by D2) as an efﬁcient means for main-
tenance of thermal homeostasis, where compromising the
action of thyroid hormone leads to obesity only when
without a thermal challenge.
So far, the link between thyroid hormone and body
weight has been anecdotal. Although patients and lay
individuals almost immediately associate hypothyroidism
with obesity, the incidence of hypothyroidism in obese
individuals is not increased, and changes in body compo-
sition during the transition from severe hypothyroidism to
mild thyrotoxicosis are meager (9–11). Given our data, the
mild apparent impact of thyroid dysfunction on metabolism
FIG. 5. Effect of temperature and/or diet on glucose tolerance. Blood glucose concentrations at the indicated time points following intraperitoneal
injection of 1 g/kg glucose in D2KO and WT animals fed with chow or high-fat diet, acclimatized to 22°C or 30°C, as indicated are shown. A: D2KO
and WT fed with chow diet, acclimatized to 22°C. B: Same as A, except acclimatization was at 30°C. C: D2KO and WT fed with high-fat diet for
8 weeks, acclimatized to 22°C. D: Same as C, except acclimatization was at 30°C. Entries are means 6 SE of four to ﬁve animals; *P < 0.01 vs. WT.
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mediated compensatory mechanisms, whereby an inverse
relationship exists between T3 and sympathetic signaling.
By inactivating the sympathetic system through acclima-
tization to 30°C, we could better appreciate the impor-
tance for thyroid hormone activation on metabolic control,
i.e., weight gain, tolerance to glucose load, and liver stea-
tosis (Fig. 3). Thus, if this hypothesis proves to be correct,
it is likely that a failure to trigger these strong compensa-
tory mechanisms would result in symptoms and signs that
would be more in line with our intuitive reasoning and
prove clinically relevant. This is particularly pertinent
given the ﬁnding of substantial amounts of functional BAT
in adult humans (26).
Liver steatosis is a novel aspect of the D2KO phenotype
(Fig. 4), which could be explained by increased NEFA
uptake, impaired b-oxidation, and/or decreased secretion
of VLDL. The lower RQ in the D2KO suggests that in-
creased NEFA is a contributing factor, but no correlation
could be found in the WT or D2KO animals between NEFA
levels and liver steatosis (Table 1). Thyroid hormone is
known to induce peroxisome proliferator–activated re-
ceptor (PPAR) (27) and b-oxidation in the liver (28) and, in
BAT, D2 is a downstream target of FGF21 through a PPAR-
mediated mechanism (29). In addition, liver delivers tri-
glycerides to peripheral tissues by production of VLDL, of
which apolipoprotein B, which is positively regulated by
thyroid hormone (in HepG2 cells), is a major component
(30). Given that serum T3 levels are normal in the D2KO
mouse (31), it is conceivable that the D2 pathway is locally
controlling thyroid hormone activation in liver and loss of
which is directly contributing to the liver phenotype in the
D2KO mouse. Although liver is known as a D1-expressing
tissue, we have found measurable liver D2 activity and
mRNA that are induced many fold and play a role in the
double LXR KO mouse phenotype (32). It is noteworthy
that hypoxia, a known inducer of the type 3 deiodinase
(D3), which inactivates thyroid hormone and creates local
hypothyroidism, aggravates liver steatosis and inhibits
PPAR expression (33). Thus, it is conceivable that an ac-
tive D2 pathway in liver upregulates genes involved in fatty
acid economy. In addition, given the wealth of information
about cross-talk between the sympathetic nervous system
and the liver (34), it is also conceivable that brain D2 plays
an indirect metabolic role in the liver via its expression in
the medial basal hypothalamus and/or other brain regions.
Although it can be debated whether diet-induced ther-
mogenesis exists and whether it exists outside of UCP1
and BAT, undoubtedly, adrenergic signaling plays a key
role in the development of or protection from obesity upon
disruption of thyroid hormone signaling. It is possible that
variations in adrenergic signaling and not BAT itself could
explain the energy balance in D2KO mice. Increased sus-
ceptibility to obesity at 30°C may be because of decreased
adrenergic signaling and not the role of D2 in diet-induced
thermogenesis per se, as has been suggested for UCP1
2/2
mice (35). It also has been recently suggested that diet-
induced thermogenesis takes place in tissues other than
BAT, such as muscle (36). D2 is highly expressed in BAT,
and, thus, it is logical to assume that the present results are
directly related to the action of D2 in this tissue. However,
we have not looked directly at oxygen consumption of
BAT, so diet-induced thermogenesis could stem from
elsewhere. D2 is expressed in a number of other tissues,
including skeletal muscle (37), and the contribution of
D2 in these tissues to metabolic control remains to be
elucidated. Finally, it could be argued that it is the mere
fact that the D2KO mice are at 22°C (and thus have an
increased metabolism) that hides the true phenotype ob-
servable at 30°C. In this case, there would be no com-
pensatory mechanisms, i.e., the increased metabolism at
22°C would simply override any other effects.
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